Your browser doesn't support javascript.
loading
Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.
Leivonen, S-K; Taskinen, M; Cervera, A; Karjalainen-Lindsberg, M-L; Delabie, J; Holte, H; Lehtonen, R; Hautaniemi, S; Leppä, S.
Afiliação
  • Leivonen SK; Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Taskinen M; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Cervera A; Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Karjalainen-Lindsberg ML; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Delabie J; Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland.
  • Holte H; Department of Pathology, Haartman Institute, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Lehtonen R; Department of Pathology, Oslo University Hospital, Oslo, Norway.
  • Hautaniemi S; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Leppä S; Research Program Unit, Medical Faculty, University of Helsinki, Helsinki, Finland.
Blood Cancer J ; 7(8): e596, 2017 08 25.
Article em En | MEDLINE | ID: mdl-28841210
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Éxons / Linfoma Difuso de Grandes Células B / Processamento Alternativo / Genes Neoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Éxons / Linfoma Difuso de Grandes Células B / Processamento Alternativo / Genes Neoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article